Benitec Biopharma (BNTC) Institutional Ownership $10.96 +0.03 (+0.27%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$10.96 -0.01 (-0.05%) As of 08/1/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Benitec Biopharma (NASDAQ:BNTC)CurrentInstitutional OwnershipPercentage52.19%Number ofInstitutional Buyers(last 12 months)18TotalInstitutional Inflows(last 12 months)$158.79MNumber ofInstitutional Sellers(last 12 months)4TotalInstitutional Outflows(last 12 months)$7.49M Get BNTC Insider Trade Alerts Want to know when executives and insiders are buying or selling Benitec Biopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data BNTC Institutional Buying and Selling by Quarter Benitec Biopharma Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails6/27/2025Goldman Sachs Group Inc.45,883$597K0.0%N/A0.175% 5/16/2025Goldman Sachs Group Inc.45,883$597K0.0%N/A0.196% 5/16/2025Infinitum Asset Management LLC1,125,000$14.64M4.7%+435.7%4.797% 5/16/2025AWM Investment Company Inc.137,977$1.80M0.2%+35.2%0.588% 5/15/2025MYDA Advisors LLC52,000$677K0.1%+4.0%0.222% 5/13/2025Informed Momentum Co LLC39,330$512K0.1%N/A0.168% 4/7/2025 GAMMA Investing LLC77,605$1.01M0.0%+1,104.3%0.331% 2/26/2025Infinitum Asset Management LLC210,000$2.65M1.4%N/A0.895% 2/18/2025AWM Investment Company Inc.102,027$1.29M0.2%-83.7%0.439% 2/17/2025Suvretta Capital Management LLC8,960,009$113.17M3.9%+1.5%38.587% Get the Latest News and Ratings for BNTC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Benitec Biopharma and its competitors with MarketBeat's FREE daily newsletter. 2/17/2025Lion Point Capital LP62,000$783K4.1%+59.0%0.267% 2/17/2025Janus Henderson Group PLC2,616,427$33.27M0.0%+198.5%11.268% 2/17/2025Ameriprise Financial Inc.35,476$448K0.0%+138.4%0.153% 2/17/2025683 Capital Management LLC35,817$452K0.0%N/A0.154% 2/14/2025Schonfeld Strategic Advisors LLC260,417$3.29M0.0%-4.5%1.122% 2/14/2025Northern Trust Corp38,200$482K0.0%+54.2%0.165% 2/14/2025Adage Capital Partners GP L.L.C.1,972,524$24.91M0.0%+134.4%8.495% 2/14/2025MYDA Advisors LLC50,000$632K0.2%N/A0.215% 2/12/2025Geode Capital Management LLC197,096$2.49M0.0%+134.7%0.849% 2/12/2025Franklin Resources Inc.2,939,287$37.12M0.0%+269.0%12.658% 2/11/2025Simplify Asset Management Inc.76,337$964K0.0%-34.5%0.329% 11/16/2024Geode Capital Management LLC83,987$772K0.0%+31.3%0.795% 11/15/2024Janus Henderson Group PLC876,523$8.03M0.0%-2.7%8.300% 11/14/2024Suvretta Capital Management LLC8,829,053$81.14M2.6%+422.0%83.640% 11/14/2024Acuta Capital Partners LLC29,800$274K0.2%N/A0.282% 11/6/2024Simplify Asset Management Inc.116,535$1.07M0.0%+127.5%1.104% 10/7/2024 GAMMA Investing LLC6,540$60K0.0%+20.3%0.070% 8/20/2024Nantahala Capital Management LLC841,395$5.88M0.3%N/A8.982% 8/13/2024Simplify Asset Management Inc.51,216$358K0.0%N/A0.547% 7/2/2024 GAMMA Investing LLC5,438$38K0.0%+53.0%0.058% 5/16/2024Janus Henderson Group PLC244,491$1.27M0.0%+35.5%9.440% 11/15/2023Adage Capital Partners GP L.L.C.189,188$572K0.0%N/A7.419% 11/15/2022Empery Asset Management LP796,837$296K1.8%N/A2.848% 11/15/2022Cantor Fitzgerald L. P.133,805$50K0.0%N/A0.478% 11/14/2022Armistice Capital LLC1,555,039$578K0.0%N/A6.025% 11/14/2022Altium Capital Management LP658,796$245K0.1%N/A2.552% 11/9/2021BlackRock Inc.19,974$71K0.0%-16.4%0.244% 8/16/2021State Street Corp21,000$89K0.0%N/A0.267% 8/13/2021Renaissance Technologies LLC42,700$181K0.0%N/A0.544% 8/13/2021Northern Trust Corp11,813$50K0.0%N/A0.150% Elon’s BIGGEST warning yet? (Ad)Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough.Click here to see why Tesla's about to prove everyone wrong... again.8/13/2021Geode Capital Management LLC34,493$146K0.0%+20.8%0.439% 8/13/2021Vanguard Group Inc.74,773$318K0.0%+43.3%0.952% 8/11/2021Bank of New York Mellon Corp14,932$63K0.0%-15.4%0.190% 7/31/2021Private Wealth Advisors LLC15,043$64K0.0%N/A0.192% 5/21/2021Citadel Advisors LLC23,253$120K0.0%N/A0.483% 5/19/2021Virtu Financial LLC22,520$116K0.0%+17.8%0.467% 5/18/2021Citadel Advisors LLC23,253$120K0.0%N/A0.483% 5/13/2021Bank of New York Mellon Corp17,653$91K0.0%N/A0.366% 5/12/2021Geode Capital Management LLC28,560$147K0.0%N/A0.593% (Data available from 1/1/2016 forward) BNTC Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of BNTC shares? During the previous two years, 19 institutional investors and hedge funds held shares of Benitec Biopharma. The most heavily invested institutionals were Suvretta Capital Management LLC ($113.17M), Franklin Resources Inc. ($37.12M), Janus Henderson Group PLC ($33.27M), Adage Capital Partners GP L.L.C. ($24.91M), Infinitum Asset Management LLC ($14.64M), Nantahala Capital Management LLC ($5.88M), and Schonfeld Strategic Advisors LLC ($3.29M).Learn more on Benitec Biopharma's institutional investors. What percentage of Benitec Biopharma's stock is owned by institutional investors? 52.19% of Benitec Biopharma's stock is owned by institutional investors. Learn more on BNTC's institutional investor holdings. Which institutional investors have been buying Benitec Biopharma's stock? Of the 18 institutional investors that purchased Benitec Biopharma's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Suvretta Capital Management LLC ($7.27M), Franklin Resources Inc. ($2.14M), Janus Henderson Group PLC ($1.80M), Adage Capital Partners GP L.L.C. ($1.32M), Infinitum Asset Management LLC ($1.13M), Nantahala Capital Management LLC ($841.40K), and Geode Capital Management LLC ($133.12K). How much institutional buying is happening at Benitec Biopharma? Institutional investors have bought a total of 14,912,394 shares in the last 24 months. This purchase volume represents approximately $158.79M in transactions. Which of Benitec Biopharma's major shareholders have been selling company stock? The following institutional investors have sold Benitec Biopharma stock in the last 24 months: AWM Investment Company Inc. ($522.97K), Simplify Asset Management Inc. ($40.20K), Janus Henderson Group PLC ($24.29K), and Schonfeld Strategic Advisors LLC ($12.40K). How much institutional selling is happening at Benitec Biopharma? Institutional investors have sold a total of 599,864 shares in the last 24 months. This volume of shares sold represents approximately $7.49M in transactions. Related Companies ELVN Major Shareholders GPCR Major Shareholders PRAX Major Shareholders ARDX Major Shareholders AVDL Major Shareholders SANA Major Shareholders DYN Major Shareholders AKBA Major Shareholders COLL Major Shareholders ZYME Major Shareholders This page (NASDAQ:BNTC) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredA new rule goes live in July — and the banks are quietly crushing itA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Benitec Biopharma Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Benitec Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BNTC Stock Alerts